Search
for
Sort by
Research 931–960 of 1000+
- Topical Minoxidil 5% Induced Male Sexual Dysfunction
- Discriminating in favour of or against men with increased risk of finasteride-related side effects?
- PD19-08 MARIJUANA, ALCOHOL, ED AND DEPRESSION: EPIDEMIOLOGIC CORRELATIONS WITH BPH/LUTS
- Adverse Effects of 5-Alpha Reductase Inhibitor Therapy in Men With Androgenetic Alopecia: Is There Cause for Concern?
- Wider clinical applications of fumaric acid esters: A useful option in psoriasis patients with multiple sclerosis
- DUTASTERIDA ORAL VERSUS FINASTERIDA ORAL NO TRATAMENTO DA ALOPECIA ANDROGENÉTICA MASCULINA: META-ANÁLISE DE EFICÁCIA E PERFIL DE EFEITOS ADVERSOS SEXUAIS
- Sexual dysfunction associated with 5α-reductase inhibitors in the treatment of androgenetic alopecia: a systematic review
- Self-Referred Late-Onset Hypogonadism Hypothesis and Testosterone Replacement Therapy in Major Depressive Disorder Under Polypharmacy: A Case Report
- Evaluation of Sexual Dysfunctions in Male Patients with Androgenetic Alopecia
- Cutting Costs, Not Care: New Models for Affordable Men’s Health Medications
- (163) Cutting Costs, Not Care: New Models for Affordable Men’s Health Medications
- SAT-148 Late Diagnosis of Klinefelter Syndrome: Overcoming Phenotypic Variability and Diagnostic Oversights
- Premarital Counseling in Relation to Common STDs, Andrological and Dermatological Disorders in Menoufia Governorate
- Risk associated with the use of 5-alpha reductase inhibitors with minoxidil in treatment of male androgenetic alopecia – literature review
- Efficacy and Safety of Low-Dose (0.2 mg) Dutasteride for Male Androgenic Alopecia: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Phase III Clinical Trial
- 8679 Case: The Sexual, Physical and Psychological Effects of Post-Finasteride Syndrome
- Multidimensional assessment of adverse events of finasteride:a real-world pharmacovigilance analysis based on FDA Adverse Event Reporting System (FAERS) from 2004 to April 2024
- Does Propecia Cause More Harms than Good: Assessing Reproductive and Non-Reproductive Effects of Finasteride on Male Health
- Treatment of hyperestrogenism in men of fertile age with testicular testosterone deficit
- The Role of Topical Finasteride in Hair Loss Management: Current Evidence and Future Perspectives
- Sustainable UV approaches supported by greenness and whiteness assessments for estimating a recently FDA-approved combination for managing urologic disorders: Tukey's test
- Beliefs and counseling practices among dermatologists regarding sexual and other adverse effects of finasteride
- Serum testosterone levels and clinical signs of hypogonadism in men with type 2 diabetes
- Summary of Hair Diseases: Cicatricial and Non-Cicatricial
- Sac Beyazlama ve Sac Kaybı Skorları ile Erektil Disfonksiyon Arasındaki Iliski
- 175 Reinventing the Selfie: Telemedicine in a Tertiary Referral Sexual Medicine Practice
- A comparison of self-reported signs of facial aging among women in Australia vs. those in the United States, United Kingdom, and Canada
- PD14-05 ECONOMIC IMPLICATIONS OF UROLOGIST PRESCRIPTION PRACTICES AMONG MEDICARE PART D BENEFICIARIES
- FINASTERIDA E CALVÍCIE ANDROGENÉTICA: em busca de uma terapêutica embasada na atenção integral à saúde do homem
- Health Warnings Can Boost Sales: Regulators Beware